Increased Transparency for Drug Price Negotiation Program Spending.
This law mandates detailed reporting on how the government spends taxpayer funds allocated to implement the drug price negotiation program. The goal is to increase oversight, ensure efficient use of these funds, and prevent waste and fraud. Citizens gain assurance that resources intended for lowering medication costs are spent as intended.
Key points
The government must regularly report to Congress on all expenditures related to the drug price negotiation program, including contracts with external entities and staffing costs.
New requirements are established to prevent fraud and abuse, ensuring that only eligible individuals and entities benefit from the lower, negotiated drug prices.
Funds designated for drug price negotiations cannot be easily transferred or used to create new, unauthorized government programs.
Expired
Citizen Poll